Upstream Bio, Inc.
UPB
$8.39
-$0.57-6.36%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -0.42% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -0.42% | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -0.42% | -- | -- | -- | |
| SG&A Expenses | 60.52% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 88.58% | -- | -- | -- | |
| Operating Income | -93.86% | -- | -- | -- | |
| Income Before Tax | -205.82% | -- | -- | -- | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -205.82% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -205.82% | -- | -- | -- | |
| EBIT | -93.86% | -- | -- | -- | |
| EBITDA | -93.93% | -- | -- | -- | |
| EPS Basic | -45.00% | -- | -- | -- | |
| Normalized Basic EPS | -109.29% | -- | -- | -- | |
| EPS Diluted | -45.00% | -- | -- | -- | |
| Normalized Diluted EPS | -109.29% | -- | -- | -- | |
| Average Basic Shares Outstanding | 371.80% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 371.80% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |